We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $347M
1-Year Est. Return 29.87%
This Fund
S&P 500
This Quarter Est. Return
-19.82%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
10 Year Est. Return
AUM
$140M
AUM Growth
-$50.9M
Cap. Flow
+$59.8M
Cap. Flow %
42.59%
Top 10 Hldgs %
56.42%
Holding
59
New
1
Increased
9
Reduced
28
Closed
6

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$63.1M
2
HXL icon
Hexcel
HXL
+$2.17M
3
HPQ icon
HP
HPQ
+$359K
4
GSBD icon
Goldman Sachs BDC
GSBD
+$257K
5
APTV icon
Aptiv
APTV
+$212K

Sector Composition

Rank Sector Weight
1 Industrials 36.81%
2 Technology 13.48%
3 Financials 13.38%
4 Healthcare 9.41%
5 Consumer Discretionary 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$13.7M 9.73%
843,216
-39,632
-4% -$882K
KEYS icon
2
Keysight
KEYS
$54.5B
$9.38M 6.68%
114,447
-4,393
-4% -$417K
EGOV
3
DELISTED
NIC Inc
EGOV
$8.04M 5.72%
363,385
-2,655
-0.7% -$54.2K
DE icon
4
Deere & Co
DE
$170B
$7.6M 5.41%
57,778
-1,934
-3% -$306K
JNJ icon
5
Johnson & Johnson
JNJ
$635B
$7.36M 5.24%
57,599
-1,667
-3% -$237K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.07T
$7.23M 5.15%
40,878
-1,614
-4% -$343K
TJX icon
7
TJX Companies
TJX
$170B
$6.66M 4.74%
144,004
-5,383
-4% -$310K
FMC icon
8
FMC
FMC
$1.42B
$6.54M 4.66%
84,140
-2,972
-3% -$276K
CNI icon
9
Canadian National Railway
CNI
$78.3B
$6.41M 4.56%
84,587
-2,484
-3% -$217K
AGM icon
10
Federal Agricultural Mortgage
AGM
$2.27B
$6.38M 4.54%
119,737
+894
+0.8% +$63.6K
NYT icon
11
New York Times
NYT
$11.6B
$5.86M 4.17%
198,003
-8,817
-4% -$303K
INGR icon
12
Ingredion
INGR
$6.38B
$5.5M 3.91%
74,494
+2,383
+3% +$205K
CMI icon
13
Cummins
CMI
$91.7B
$5.3M 3.77%
40,830
-281
-0.7% -$43.8K
GD icon
14
General Dynamics
GD
$105B
$5.07M 3.61%
40,200
-548
-1% -$91K
HPQ icon
15
HP
HPQ
$23.5B
$4.53M 3.23%
290,903
+17,739
+6% +$359K
LH icon
16
Labcorp
LH
$24.3B
$4.42M 3.15%
43,844
-1,849
-4% -$266K
CL icon
17
Colgate-Palmolive
CL
$72.6B
$4.31M 3.07%
66,339
-621
-0.9% -$43.8K
APTV icon
18
Aptiv
APTV
$12B
$3.71M 2.64%
80,740
+2,697
+3% +$212K
OZK icon
19
Bank OZK
OZK
$5.49B
$3.43M 2.44%
218,031
+4,750
+2% +$122K
HXL icon
20
Hexcel
HXL
$8.32B
$3.41M 2.43%
98,741
+33,531
+51% +$2.17M
JKHY icon
21
Jack Henry & Associates
JKHY
$10.7B
$2.69M 1.92%
18,234
-695
-4% -$108K
TCP
22
DELISTED
TC Pipelines LP
TCP
$2.24M 1.59%
83,314
-260
-0.3% -$9.71K
AAPL icon
23
Apple
AAPL
$4.89T
$812K 0.58%
13,176
-1,440
-10% -$106K
XOM icon
24
ExxonMobil
XOM
$651B
$754K 0.54%
20,538
-615
-3% -$34K
KO icon
25
Coca-Cola
KO
$354B
$597K 0.43%
13,945
-561
-4% -$30.3K

Similar funds

Weybosset Research & Management's Q1 2020 Portfolio in Review

As of Q1 2020, Weybosset Research & Management held 59 positions worth $140M, down 27% from $191M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Weybosset Research & Management deployed $59.8M of net new capital in Q1 2020, opening 1 new position and adding to 9 existing holdings. Its largest new stake was Goldman Sachs BDC: 13,610 shares worth $158K.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, up from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Copart, an estimated $882K trimmed.

  • Weybosset Research & Management's largest Q1 2020 buy was Goldman Sachs BDC: 13,610 shares worth $158K.
  • Weybosset Research & Management added most to Berkshire Hathaway Class A in Q1 2020, an estimated $63.1M increase.
  • Weybosset Research & Management's biggest Q1 2020 reduction was Copart, cutting an estimated $882K.
  • Weybosset Research & Management fully exited Livent Corporation in Q1 2020, selling an estimated $1.07M.
  • Weybosset Research & Management's ten largest holdings make up 56% of its $140M portfolio in Q1 2020.
  • Weybosset Research & Management opened 1 new position and closed 6 in Q1 2020.
  • Weybosset Research & Management's portfolio value fell 27% quarter-over-quarter to $140M.

Based on Weybosset Research & Management's 13F filing for Q1 2020, filed 13 Apr 2020.